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Background
The purpose of this study was to examine the benefits
of inositol-stabilized arginine silicate (ASI; Nitrosigine®)
as a workout ingredient in healthy adults. ASI has been
previously shown to significantly enhance blood levels of
arginine up to six hours post-dose and increase nitric
oxide levels. To investigate reports of enhanced energy,
increased muscle pump and stamina during workouts,
and faster muscle recovery post-workout, ASI (1,500mg/
day) was tested in a double-blind placebo-controlled
crossover-design (DBPC-X) study using the POMS
vigor-activity and fatigue-inertia sub-scores, blood flow
measurements, leg circumference measurements, and
biomarkers of muscle recovery (creatine kinase (CK)
and lactate dehydrogenase (LDH)) as outcome measures.
Methods
The DBPC-X study was conducted in male subjects (N =
16 per group) who had limited exercise routines prior to
participating in the study. These subjects took ASI daily
for 4 days. Subjects had baseline measurements drawn at
the hour 0 visit, took the study product, and completed
an intense leg extension exercise protocol to induce muscle soreness. Subjects returned after 24, 48, and 72 hours
for additional study measurements. After 72 hours, subjects repeated the leg extension exercise protocol. There
was a seven-day washout between test products.
Between-product assessments were primary endpoints
and within-product assessments secondary endpoints.
Results
Sixteen (16) healthy male subjects (19-33 years of age)
completed the study. Perceived energy, measured using
the POMS vigor-activity sub-scores, significantly increased

after 72 hours compared to placebo (p = 0.039). At 72
hours, perceived fatigue, measured using the POMS fatigue-inertia sub-scores, significantly decreased in the ASI
group (p = 0.041) from pre-dose, compared to a non-significant change in the placebo group (p = 0.580); p = 0.055
between groups.
Hyperemia, measured using leg circumference, increased
significantly in the ASI group by 1.8cm (p = 0.001) at
72 hours from pre-dose, compared to a non-significant
increase in the placebo group by 0.8cm (p = 0.091);
p = 0.070 between groups.
Blood flow, measured by blood velocity through the
femoral artery using a Doppler Ultrasound, increased
59.9 cm/s in the ASI group (p < 0.005) and 49.9cm/s in
the placebo group (p < 0.005) after exercise on Day 3;
p = 0.2 between groups.
CK levels significantly decreased in the ASI group at 24
(p = 0.040), 48 (p = 0.017) and 72 (p = 0.034) hours postexercise compared to the placebo group. Immediately
post-exercise at the hour 0 visit, ASI supplementation led
to 44% less muscle damage, measured by CK levels, than
placebo (p = 0.057). LDH levels significantly increased
from baseline immediately after exercise in the placebo
group (p = 0.015), but not in the ASI group (p = 0.366);
p = 0.133 between groups. No safety concerns were
raised by this study.

Conclusion
Both primary and secondary endpoints show that daily
doses of ASI prior to workout significantly increased preworkout energy levels, increased muscle pump immediately following a workout, and decreased biomarkers of
muscle damage immediately after a workout and during
recovery. These results demonstrate multiple benefits of
ASI as a functional workout ingredient.

* Correspondence: sroodojalvo@nutrition21.com
1
Nutrition 21, LLC, Purchase, Harrison, NY, USA
Full list of author information is available at the end of the article
© 2015 Rood-Ojalvo et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Rood-Ojalvo et al. Journal of the International Society of Sports Nutrition 2015, 12(Suppl 1):P14
http://www.jissn.com/content/12/S1/P14

Page 2 of 2

Authors’ details
1
Nutrition 21, LLC, Purchase, Harrison, NY, USA. 2StrengthPro Inc, Golden, CO,
USA. 3Emory University, Atlanta, GA, USA.
Published: 21 September 2015

doi:10.1186/1550-2783-12-S1-P14
Cite this article as: Rood-Ojalvo et al.: The benefits of inositol-stabilized
arginine silicate as a workout ingredient. Journal of the International
Society of Sports Nutrition 2015 12(Suppl 1):P14.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

